In: PATENT NEWS
AbbVie Announces HUMIRA® (adalimumab) Patent License with Mylan PR Newswire (press release) AbbVie, Mylan enter patent license agreement for biosimilar adalimumab product Healio AbbVie (ABBV) Granted HUMIRA (adalimumab) Patent License with Mylan (MYL) StreetInsider.com Full coverage
In: DESIGN NEWS
On Brexit, McLeod explained, “the key issues from a UK perspective are the cloning of registered trademarks and designs onto the UK register, …
In: PATENT NEWS
United States: Patent Infringers Can Be Sued In A Venue Where They Do Not Own Own Or Lease Property If They Hold … Mondaq News Alerts Full coverage
In: TRADEMARK NEWS
Trademark Licenses . . . Again (Update No. 2) Lexology Full coverage
In: PATENT NEWS
Law360 (July 16, 2018, 7:34 PM EDT) — Blackbird Technologies, a Boston patent litigation company founded by former BigLaw partners, notched a …
In: COPYRIGHT NEWS
China launches campaign against online copyright infringement Xinhua Full coverage
In: PATENT NEWS
Amphastar cannot collect $100 mln during Momenta drug patent appeal – judge Reuters Full coverage
In: PATENT NEWS
West-Ward had argued in its June petition that U.S. Patent No. 8,586,610 covers a natural process barred from protection by Mayo, so the panel’s 2-1 …
In: PATENT NEWS
Still it will often be possible to combine the advantages of intellectual property rights and protection of secrecy. While patents may be obtained for …
In: PATENT NEWS
Blue Spike Hits Roku With ITC Petition On Streaming Patents … products that violate the Texas company’s intellectual property rights, asking the U.S. …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION